Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Mapping of Pro-Alzheimer’s Gene Expression Through Cell-specific Profiling

EF 2024-25

Résumé
Alzheimer's Disease (AD), the leading cause of dementia, is the most prevalent neurodegenerative disease, affecting over 55 million people worldwide. AD is characterized by progressive memory loss and cognitive decline due to neural degeneration beginning in the hippocampus and entorhinal cortex. While previous literature on the a B-amyloid (AB) cascade hypothesis suggests that AB accumulation triggers downstream inflammation and synaptic dysfunction within the hippocampus and entorhinal cortex, there is a persistent knowledge gap regarding which specific cell types exhibit altered levels of expression for key pro-AD genes for Amyloid Precursor Protein (App), which generates of AB, or Presenilin-1 (Psen1), essential for producing AB toxic oligomers like AB-42. This proposed research aims to elucidate the specific cell types involved in driving pathogenesis of AD within the hippocampus and entorhinal cortex through advanced spatial transcriptomics techniques. The research will compare specific cell type gene expression in 5xFAD mice group, the gold standard model for AD due to its overexpression of pro-AD genes, versus the standard control C57BL/6 mice group. Novel RNA-visualization techniques like single-cell spatial transcriptomics will be paired with fluorescence in situ hybridization to build a holistic and clear understanding of which cells are possessing abnormal gene expression levels for App and Psen1. After tissue has been collected from the mice, sophisticated statistical analyses will be employed to decipher the immense sequencing data to determine the patterns of gene dysregulation related to AD. Understanding the molecular mechanisms of AD is essential to developing therapeutic treatments targeted at curing AD, rather than merely alleviating the symptoms.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529618
Name
Tan Neilan T
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mapping of Pro-Alzheimer’s Gene Expression Through Cell-specific Profiling
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
5xfad Mouse Model; Alzheimer'S Disease; Amyloid Precursor Protein; B-Amyloid; Entorhinal Cortex; Fluorescence In Situ Hybridization; Hippocampus; Presenilin-1; Single-Cell Rna Sequencing; Spatial Transcriptomics
Abstract
Alzheimer's Disease (AD), the leading cause of dementia, is the most prevalent neurodegenerative disease, affecting over 55 million people worldwide. AD is characterized by progressive memory loss and cognitive decline due to neural degeneration beginning in the hippocampus and entorhinal cortex. While previous literature on the a B-amyloid (AB) cascade hypothesis suggests that AB accumulation triggers downstream inflammation and synaptic dysfunction within the hippocampus and entorhinal cortex, there is a persistent knowledge gap regarding which specific cell types exhibit altered levels of expression for key pro-AD genes for Amyloid Precursor Protein (App), which generates of AB, or Presenilin-1 (Psen1), essential for producing AB toxic oligomers like AB-42. This proposed research aims to elucidate the specific cell types involved in driving pathogenesis of AD within the hippocampus and entorhinal cortex through advanced spatial transcriptomics techniques. The research will compare specific cell type gene expression in 5xFAD mice group, the gold standard model for AD due to its overexpression of pro-AD genes, versus the standard control C57BL/6 mice group. Novel RNA-visualization techniques like single-cell spatial transcriptomics will be paired with fluorescence in situ hybridization to build a holistic and clear understanding of which cells are possessing abnormal gene expression levels for App and Psen1. After tissue has been collected from the mice, sophisticated statistical analyses will be employed to decipher the immense sequencing data to determine the patterns of gene dysregulation related to AD. Understanding the molecular mechanisms of AD is essential to developing therapeutic treatments targeted at curing AD, rather than merely alleviating the symptoms.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tan, Neilan T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~